LONDON (Alliance News) - Physiomics PLC Monday said it has signed a contract with a new speciality pharmaceuticals customer to investigate how one of the client's new candidate drugs shrinks tumours.
Physiomics scientists will use systems biology approaches to map the possible pathways by which the drug could act, it said in a statement without giving any financial details. The analysis will be used to narrow down possible mechanisms and suggest new experiments that the client can perform to home in on one mechanism.
"If successful, the directors hope that Physiomics will be able to offer its other modelling services to this new client as the project progresses," the company said in a statement.
Physiomics shares were up 31.6% at 0.25 pence early Monday, the biggest gainer on AIM.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...


(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Friday and not separately reported by Alliance ...


(Sharecast News) - Mathematical modelling and biostatistics firm Physiomics said on Wednesday that it had secured a new contract with long-standing cl...


(Alliance News) - Physiomics PLC on Monday predicted annual results "ahead of expectations", and noted that contract wins have reached "a record high"...


(Sharecast News) - Data science and biostatistics firm Physiomics said on Monday that both total income and pre-tax losses would exceed market expecta...


(Alliance News) - Physiomics PLC on Tuesday reported the signing of a new contract, as it looks to accelerate the development of a "promising" drug pr...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.


(Sharecast News) - Data science and biostatistics company Physiomics said on Monday that it had secured two new contracts with a UK-headquartered clin...


(Sharecast News) - Data science and biostatistics company Physiomics said on Thursday that it has secured a "sizeable contract extension award" with a...


(Alliance News) - Physiomics PLC on Friday said it has won a contract with a new client in the UK.